Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
Open Access
- 22 September 2022
- journal article
- research article
- Published by Elsevier in JHEP Reports
- Vol. 5 (1) , 100596
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia, Innovación y Universidades
- Generalitat de Catalunya
This publication has 16 references indexed in Scilit:
- A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsAmerican Journal of Gastroenterology, 2020
- Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinicsLiver International, 2020
- Advances in non-invasive assessment of hepatic fibrosisGut, 2020
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver diseaseJournal of Hepatology, 2019
- Non-alcoholic fatty liver disease and the interface between primary and secondary careThe Lancet Gastroenterology & Hepatology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisAmerican Journal of Gastroenterology, 2017
- Screening for liver fibrosis in the general population: a call for actionThe Lancet Gastroenterology & Hepatology, 2016
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseHepatology, 2014
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005